Marshall Wace
FBRX icon

Marshall Wace’s Forte Biosciences FBRX Stock Holding History

Marshall Wace’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.89M Buy
150,307
+114,010
+314% +$3.28M ﹤0.01% 1423
2025
Q4 		$990K Buy
36,297
+17,132
+89% +$300K ﹤0.01% 1939
2025
Q3 		$287K Buy
+19,165
New +$221K ﹤0.01% 2446
2021
Q3 		– Sell
-1,063
Closed -$893K – 3138
2021
Q2 		$893K Buy
1,063
+812
+324% +$732K ﹤0.01% 1875
2021
Q1 		$215K Buy
+251
New +$206K ﹤0.01% 2237
2019
Q1 		– Sell
-107
Closed -$328K – 1821
2018
Q4 		$328K Buy
+107
New +$461K ﹤0.01% 1207

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Marshall Wace's FBRX Position: Q1 2026 in Review

Marshall Wace increased its Forte Biosciences (FBRX) stake by 314% in Q1 2026, buying an estimated $3.28M and bringing the position to 150,307 shares worth $3.89M. The position accounts for ﹤0.01% of the portfolio, ranked #1423.

Marshall Wace first reported a position in FBRX in Q4 2018 and has held it in 6 quarters since. 68 funds tracked by Wall St. Rank hold FBRX as of Q1 2026.

  • Marshall Wace held 150,307 shares of Forte Biosciences worth $3.89M as of Q1 2026.
  • Marshall Wace bought 114,010 Forte Biosciences shares in Q1 2026, an estimated $3.28M.
  • Forte Biosciences made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1423 holding.
  • Marshall Wace first reported a position in Forte Biosciences in Q4 2018 and has held it in 6 quarters since.
  • 68 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.